Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> GSK Hit With Thalidomide Birth Defect Suit
FDAnews Drug Daily Bulletin
Aug. 13, 2012
| Vol. 9 No. 158
GSK Hit With Thalidomide Birth Defect Suit
A group of 11 plaintiffs sued GlaxoSmithKline and other pharmaceutical companies in Pennsylvania court, alleging they suffered birth defects after their mothers took the morning sickness drug thalidomide in the late 1950s and early 1960s.
Law360
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Mylan Launches Generic Tricor Tablets
Is the FDA Approving too Many Drugs Starting with X and Z?
Court Rejects Merck Deal Over Vioxx
Citizens in Poor EU States Can’t Afford Medicines, Health Promoters Say